Section Arrow
Quote
PMN.NASDAQ
- Promis Neurosciences Inc.
Quotes are at least 15-min delayed:2026/04/13 04:34 EDT
Pre Market
Last
 --
-- (--)
Bid
12.4
Ask
13.9
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 12.6
+0.1 (+0.80%)
Day High 
13.23 
Prev. Close
12.5 
1-M High
23.975 
Volume 
35.52K 
Bid
12.4
Ask
13.9
Day Low
11.88 
Open
11.88 
1-M Low
10.565 
Market Cap 
112.10M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 12.6 
20-SMA 15.38 
50-SMA 16.75 
52-W High 39.75 
52-W Low 6.27 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-22.61/-5.54
Enterprise Value
115.97M
Balance Sheet
Book Value Per Share
-0.14
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CUECue Biopharma0.5019+0.209+71.36%-- 
Pre Market 0.433 -0.0689 -13.73%
QNCXQuince Therapeutics0.1363+0.0126+10.19%-- 
Pre Market -- -- --
VRAXVirax Biolabs Group Limited0.1041-0.0308-22.83%-- 
Pre Market 0.19 +0.0859 +82.52%
ZNTLZentalis Pharmaceuticals6.61+2.19+49.55%-- 
Pre Market 6.5103 -0.0997 -1.51%
IOVAIovance Biotherapeutics3.7-0.31-7.73%-- 
Pre Market 3.72 +0.02 +0.54%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimers disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.